Fortitude Family Office’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3K | Sell |
106
-11
| -9% | -$239 | ﹤0.01% | 1123 |
|
|
2025
Q1 | $2.84K | Hold |
117
| – | – | ﹤0.01% | 857 |
|
|
2024
Q4 | $2.44K | Hold |
117
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q3 | $2.33K | Hold |
117
| – | – | ﹤0.01% | 972 |
|
|
2024
Q2 | $1.81K | Hold |
117
| – | – | ﹤0.01% | 817 |
|
|
2024
Q1 | $1.87K | Hold |
117
| – | – | ﹤0.01% | 833 |
|
|
2023
Q4 | $1.97K | Buy |
+117
| New | +$1.97K | ﹤0.01% | 872 |
|